From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Kooth – more contract controversy, though natch with it having the ominous combination of being an AIM Awards 2024 “winner” and that being “Diversity Champion”!

By Steve Moore | Friday 25 October 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Most recently on ‘therapeutic technology platform’ company Kooth (KOO) I wrote just a week ago ‘with the ominous combination of being an AIM Awards 2024 “winner” and that being “Diversity Champion”, now contract disappointment (natch!)’. That was, re. “its first pilot contract in Pennsylvania… the company has received communication from the State of Pennsylvania regarding the contract, exercising the State's right to terminate with a 30 day notice period”, which I concluded didn’t bode well for contracts elsewhere with the shares then down to around 240p. They had subsequently slipped further and then fell significantly again yesterday to 176p, bringing today a “Statement regarding share price movement”.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 20:33:13